Cardinal Health (CAH) Stock Looks Strong On Returns Yet Above Fair Value
Cardinal Health (CAH) has shown significant share price gains over the past five years, returning 365.1%, including 46.0% last year. Despite strong performance and recent enthusiasm for its specialty healthcare business, the stock appears overvalued with a P/E ratio of 35.2x compared to an industry average of 24.9x and a fair P/E of 29.2x. This suggests that the current price already incorporates high expectations for future execution, narrowing the margin for error against competitive and regulatory pressures.




























